Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T06:56:21.068Z Has data issue: false hasContentIssue false
  • English
  • Français

Dexamethasone suppression test in mentally handicapped subjects

Published online by Cambridge University Press:  13 June 2014

Verena Keane  and
Saroj Soni
Verena Keane
Affiliation:
Salford Health Authority, Hope Hospital, Eccles Old Road, Salford, M6 8HD
Saroj Soni
Affiliation:
Salford Health Authority, Hope Hospital, Eccles Old Road, Salford, M6 8HD
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective: This study investigated the frequency of abnormal Dexamethasone Suppression Test (DST) in a randomly selected group of mentally handicapped subjects. Method: Forty three subjects living in the community were selected and assessed on a variety of clinical rating scales including Hamilton Rating Scale for Depression (HDS) and Wessex Case Register Form (WCRF). DST was conducted on all the patients and the findings correlated with demographic and clinical variables. Groups defined by DST status were also compared using t-test. In subjects who showed an abnormal response, clinical assessments and DST was repeated after 3 months. Results: Only 7 of 43 subjects showed an abnormal response which did not correlate with either the severity of affective symptoms or the presence or absence of behavioural difficulties. Six of the 7 DST positive subjects were either severely or profoundly impaired on DSM-III criteria indicating that the underlying brain pathology may be pathogenetically important. This was supported by the observation that abnormal DST response was enduring at follow up. Conclusions: The findings suggest that DST may be of little value as a diagnostic tool in the mentally handicapped.

Keywords

Dexamethasone suppression testDSTMental handicapDepressionLife events
Type
Original Papers
Information
Irish Journal of Psychological Medicine , Volume 9 , Issue 2 , November 1992 , pp. 101 - 105
Copyright
Copyright © Cambridge University Press 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Reid, AH. Psychoses in adult mental defectives: manic depressive psychosis. Br J Psychiatry 1972; 120: 205–212.CrossRefGoogle ScholarPubMed
2.Heaton-Ward, A. Psychosis in mental handicap: the tenth Blake Marsh lecture delivered before the Royal College of Psychiatrists, Feburary 2, 1976. Br J Psychiatry 1977; 130: 525–533.CrossRefGoogle Scholar
3.Sovner, R, Hurley, AD. Do the mentally retarded suffer from mental illness? Arch Gen Psychiatry 1983; 40: 61–67.CrossRefGoogle Scholar
4.Primrose, DA. A survey of 500 consecutive admissions to a subnormality hospital from 1st January 1968 to 31st December 1970. Br J Subnormality 1971; 27: 25–28.CrossRefGoogle Scholar
5.Craft, M. A North Wales experiment in subnormality care. Br J Psychiatry 1971; 118: 199–206.CrossRefGoogle ScholarPubMed
6.James, FESnaith, RP. Psychiatric illness in mental handicap. London: Royal College of Psychiatrists Gaskell Press, 1979.Google Scholar
7.Ballinger, BR. A standardised assessment of personality disorder in mental handicap. Br J Psychiatry 1987; 150: 108–109.CrossRefGoogle ScholarPubMed
8.Ballinger, BR, Armstrong, J, Presly, AS, Reid, AH. Use of a standardised interview in mentally handicapped patients. Br J Psychiatry 1975; 127: 540–544.CrossRefGoogle ScholarPubMed
9.Sireling, L. Depression in mentally handicapped patients: diagnostic and neuroendocrine evaluation. Br J Psychiatry 1986; 149: 274–278.CrossRefGoogle ScholarPubMed
10.Carrol, BJ, Feinberg, M, Greden, JF, Tarika, J, Albala, A, Haskett, RF, et al.A specific laboratory test for the diagnosis of melancholia: standardisation, validation and clinical utility. Arch Gen Psychiatry 1981; 38: 15–22.CrossRefGoogle Scholar
11.Carroll, BJ. The dexamethasone suppression test for melancholia. Br J Psychiatry 1982; 140: 292–304.CrossRefGoogle ScholarPubMed
12.Bueno, JA, Sabanes, F, Gascon, J, Gasto, C, Salamoro, M. Dexamethasone suppression test in patients with panic disorder and secondary depression. Arch Gen Psychiatry 1985; 41: 723–724.Google Scholar
13.Carnes, M, Smith, JC, Kalin, NH. Effects of chronic medical illness and dementia on the dexamethasone suppression test. J Am Geriatr Soc 1983; 31: 267–271.CrossRefGoogle ScholarPubMed
14.Herz, MI, Giovanni, AF, Molnar, G, Edwards, L. The dexamethasone suppression test in newly hospitalised schizophrenic patients. Am J Psychiatry 1985; 142(1): 127–129.Google Scholar
15.Spar, JEGerner, R. Does dexamethasone suppression test distinguish dementia from depression? Am J Psychiatry 1982; 139(2): 238–240.Google ScholarPubMed
16.Berger, M, Pirkie, K-M, Doerr, P, Kreig, J-C, Von Zerssen, D. The limited utility of the desamethasone suppression text for the diagnostic process in psychiatry. Br J Psychiatry 1984: 145: 372–382.CrossRefGoogle Scholar
17.McKeith, IG, Clinical use of the DST in a psychogeriatric population. Br J Psychiatry 1984; 145: 389–393.CrossRefGoogle Scholar
18.Shrimanker, J, Soni, SD, McMurray, J. Dexamethasone suppression test in dementia and depression: clinical and biological correlates. Br J Psychiatry 1989; 154: 372–377.CrossRefGoogle Scholar
19.Shrimanker, J, Soni, SD, Sampath, G. Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients. Acta Psychiatr Scand 1988; 77: 712–718.CrossRefGoogle Scholar
20.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington DC: American Psychiatric Association, 1980.Google Scholar
21.Privitera, MR, Greden, JF, Gardner, RW, Ritchie, JC, Carroll, BJ. Interference by carbamazepine with the dexamethasone suppression text. Biol Psychiatry 1982; 17(5): 611–620.Google Scholar
22.Beckett, GJ, Gray, SM, Seth, J. Immunoassays for clinical chemistry. 2nd ed. Hunter, WM, Corrie, JET, editors. London: Churchill and Livingstone, 1982: 201–202.Google Scholar
23.Hamilton, M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967; 6: 278–297.CrossRefGoogle ScholarPubMed
24.D.H.S.S. Helping mentally handicapped people in hospital. Appendix I: Wessex case register form: a report to the secretary of state for social services by the National Development Group for the Mentally Handicapped (Chairman: P. Mittler). London: Department of Health and Social Security, 1978: 97–98.Google Scholar
25.Holmes, TH, Rahe, RH. The social readjustment scale. J Psychosom Res 1967; 11: 213–218.CrossRefGoogle Scholar
26.Reid, AH. Diagnosis of psychiatric disorder in the severly and profoundly retarded patient. J Roy Soc Med 1980; 73: 607–609.CrossRefGoogle Scholar
27.Wright, EC. The presentation of mental illness in mentally retarded adults. Br J Psychiatry 1982; 141: 496–502.CrossRefGoogle ScholarPubMed
28.Bowie, PCW, Beaini, AL. Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives. Br J Psychiatry 1985: 147: 30–35.CrossRefGoogle Scholar
29.Greden, JF, Albala, AA, Haskett, RF, James, NM, Goodman, L, Steiner, M, Carroll, BJ. Normalisation of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. Biol Psychiatry 1980: 15: 449–458.Google Scholar
30.Swarz, GMDunner, FJ. Dexamethasone suppression testing of alcoholics. Arch Gen Psychiatry 1982: 39: 1309–1312.CrossRefGoogle Scholar
31.Soni, SD, Mallik, A, Harris, V, Shrimanker, J, McMurray, J. Dexamethasone suppression test in chronic schizophrenia. Psychiatry & Psychobiology 1988; 3: 189–194.CrossRefGoogle Scholar
32.Abou-Saleh, MT, Spalding, EM, Kellett, JM, Coppen, A. Dexamethasone suppression test in dementia. Int J Geriatr Psychiatry 1987; 2: 59–65.CrossRefGoogle Scholar
33.Balldin, J, Gottfries, C, Karlsson, I, Lindstedt, G, Langstrom, G, Walinder, J. Dexamethasone suppression test and serum prolactin in dementia disorders. Br J Psychiatry 1983; 143: 277–281.CrossRefGoogle ScholarPubMed
34.Greenwald, BS, Mathe, AA, Mohs, RC, Levy, MI, Johns, CA, Davis, KL. Cortisol and Alzheimer's disease II: dexamethasone suppression, dementia severity and affective symptoms. Am J Psychiatry 1986; 143(4): 442–446.Google ScholarPubMed
35.Soni, S, Keane, V, Soni, SD. Dexamethasone suppression text and response to antidepressants in depressed, mentally handicapped subjects. J Ment Defic Res 1991 (in press).Google Scholar
36.Rahe, RHArthur, RS. Life change patterns surrounding illness experiences. J Psychosom Res 1968; 11: 341–345.CrossRefGoogle Scholar
37.Morrison, JR, Hudgens, RW, Barchha, R. Life events and psychiatric disorder. Br J Psychiatry 1968; 114: 423–432.CrossRefGoogle Scholar
38.Faykel, ES, Myers, JK, Dienelt, MM, Klerman, GL, Lindethal, JJ, Pepper, MP. Life events and depression: a controlled study. Arch Gen Psychiatry 1969; 21: 753–760.Google Scholar
39.Soni, S, Monaghan, T. Effects of significant life events on the behaviour of mentally handicapped subjects in the community. Paper presented at the First European Conference on Mental Handicap and Medical Care held at Noordwijkerhout, the Netherlands on 21-24 04 1991 (Abstract 51).Google Scholar
40.Ghaziuddin, M. Behavioural disorder in the mentally handicapped: role of life events. Br J Psychiatry 1988; 152: 683–686.CrossRefGoogle ScholarPubMed
41.Cohen, J. Statistical power analysis for the behavioural sciences. New York: Academic Press, 1977.Google Scholar
42.Bird, KDHall, W. Statistical power in psychiatric research. Aust N Z J Psychiatry 1986; 20: 189–200.CrossRefGoogle ScholarPubMed